🇺🇸 FDA
Patent

US 12168041

Methods and compositions for CNS delivery of arylsulfatase A

granted A61KA61K35/76A61K35/761

Quick answer

US patent 12168041 (Methods and compositions for CNS delivery of arylsulfatase A) held by Takeda Pharmaceutical Company Limited expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/76, A61K35/761, A61K38/46, A61K38/465